{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:10:04Z","timestamp":1793459404709,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A growing number of recent investigations on the human genome, gut microbiome, and proteomics suggests that the loss of mucosal barrier function, particularly in the gastrointestinal tract, may substantially affect antigen trafficking, ultimately influencing the close bidirectional interaction between the gut microbiome and the immune system. This cross-talk is highly influential in shaping the host immune system function and ultimately affecting the outcome of interventions. We hypothesized that the loss of mucosal barrier in the gut may be associatedto acute and chronic periprosthetic joint infections (PJI). Zonulin, soluble CD14 (sCD14), and lipopolysaccharide (LPS) were tested in plasma as part of a prospective cohort study of patients undergoing primary arthroplasty or revision arthroplasty because of an aseptic failure or PJI (as defined by the 2018 criteria). All blood samples were collected before antibiotic administration. Samples were tested using commercially available enzyme-linked immunosorbent assays as markers for gut permeability. A total of 134 patients were included in the study of which 44 patients had PJI (30 chronic and 14 acute), and the remaining 90 patients were categorized as non-infected that included 64 patients revised for aseptic failure, and 26 patients undergoing primary total joint arthroplasty. Both Zonulin (7.642\u2009\u00b1\u20096.077\u00a0ng\/mL vs 4.560\u2009\u00b1\u20093.833\u00a0ng\/mL; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and sCD14 levels (555.721\u2009\u00b1\u2009216.659\u00a0ng\/mL vs 396.872\u2009\u00b1\u2009247.920\u00a0ng\/mL; <jats:italic>p<\/jats:italic>\u2009=\u20090.003) were significantly elevated in the PJI group compared to non-infected cases. Higher levels of Zonulin were found in acute infections compared to chronic PJI (11.595\u2009\u00b1\u20096.722\u00a0ng\/mL vs. 5.798\u2009\u00b1\u20094.841\u00a0ng\/mL; <jats:italic>p<\/jats:italic>\u2009=\u20090.005). This prospective study reveals a possible link between gut permeability and the \u2018gut-immune-joint axis\u2019 in PJI. If this association continues to be borne out with a larger cohort and more in-depth analysis, it will have a clinically significant implication in managing patients with PJI. It may be that in addition to the administration of antimicrobials, patients with PJI and other orthopaedic infections may benefit from administration of gastrointestinal modulators such as pro and prebiotics.<\/jats:p>","DOI":"10.1038\/s41598-022-19034-6","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T15:03:05Z","timestamp":1662390185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Gut permeability may be associated with periprosthetic joint infection after total hip and knee arthroplasty"],"prefix":"10.1038","volume":"12","author":[{"given":"Emanuele","family":"Chisari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongeun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Wouthuyzen-Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Parvizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"19034_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0140-6736(14)61798-0","volume":"387","author":"BH Kapadia","year":"2016","unstructured":"Kapadia, B. H. et al. Periprosthetic joint infection. Lancet 387, 386\u2013394 (2016).","journal-title":"Lancet"},{"key":"19034_CR2","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/jor.22907","volume":"33","author":"K Nishitani","year":"2015","unstructured":"Nishitani, K. et al. Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors. J. Orthop. Res. 33, 1311\u20131319 (2015).","journal-title":"J. Orthop. Res."},{"key":"19034_CR3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/jbmr.3055","volume":"32","author":"KL de Mesy Bentley","year":"2017","unstructured":"de Mesy Bentley, K. L. et al. Evidence of Staphylococcus aureus deformation, proliferation, and migration in canaliculi of live cortical bone in murine models of osteomyelitis. J. Bone Miner. Res. 32, 985\u2013990 (2017).","journal-title":"J. Bone Miner. Res."},{"key":"19034_CR4","unstructured":"The Group of Investigators for Streptococcal Prosthetic Joint Infection et al. The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study. Clin. Infect. Dis. 64, 1742\u20131752 (2017)."},{"key":"19034_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1302\/0301-620X.99B7.BJJ-2016-1293.R1","volume":"99B","author":"BV Bloch","year":"2017","unstructured":"Bloch, B. V., Shah, A., Snape, S. E., Boswell, T. C. J. & James, P. J. Primary hip and knee arthroplasty in a temporary operating theatre is associated with a significant increase in deep periprosthetic infection. Bone Jt. J. 99B, 917\u2013920 (2017).","journal-title":"Bone Jt. J."},{"key":"19034_CR6","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3928\/0147-7447-20051101-13","volume":"28","author":"JE Block","year":"2005","unstructured":"Block, J. E. & Stubbs, H. A. Reducing the risk of deep wound infection in primary joint arthroplasty with antibiotic bone cement. Orthopedics 28, 1334\u20131345 (2005).","journal-title":"Orthopedics"},{"key":"19034_CR7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.arth.2015.03.042","volume":"30","author":"BD Springer","year":"2015","unstructured":"Springer, B. D. The diagnosis of periprosthetic joint infection. J. Arthroplas. 30, 908\u2013911 (2015).","journal-title":"J. Arthroplas."},{"key":"19034_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2217\/fmb.14.64","volume":"9","author":"SJ McConoughey","year":"2014","unstructured":"McConoughey, S. J. et al. Biofilms in periprosthetic orthopedic infections. Future Microbiol. 9, 987\u20131007 (2014).","journal-title":"Future Microbiol."},{"key":"19034_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1302\/2046-3758.94.BJR-2019-0205.R1","volume":"9","author":"H Zhu","year":"2020","unstructured":"Zhu, H., Jin, H., Zhang, C. & Yuan, T. Intestinal methicillin-resistant Staphylococcus aureus causes prosthetic infection via \u2018Trojan Horse\u2019 mechanism: Evidence from a rat model. Bone Jt. Res. 9, 152\u2013161 (2020).","journal-title":"Bone Jt. Res."},{"key":"19034_CR10","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/SLA.0000000000002173","volume":"267","author":"MA Krezalek","year":"2018","unstructured":"Krezalek, M. A. et al. Can methicillin-resistant Staphylococcus aureus silently travel from the gut to the wound and cause postoperative infection? Modeling the \u2018trojan Horse Hypothesis\u2019. Ann. Surg. 267, 749\u2013758 (2018).","journal-title":"Ann. Surg."},{"key":"19034_CR11","doi-asserted-by":"crossref","unstructured":"Alverdy, J. C., Hyman, N. & Gilbert, J. Re-examining causes of surgical site infections following elective surgery in the era of asepsis. The Lancet Infectious Diseases vol. 20 e38\u2013e43 (Lancet Publishing Group, 2020).","DOI":"10.1016\/S1473-3099(19)30756-X"},{"key":"19034_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41413-019-0061-z","volume":"7","author":"EA Masters","year":"2019","unstructured":"Masters, E. A. et al. Evolving concepts in bone infection: redefining \u201cbiofilm\u201d, \u201cacute versus chronic osteomyelitis\u201d, \u201cthe immune proteome\u201d and \u201clocal antibiotic therapy\u201d. Bone Res. 7, 1\u201318 (2019).","journal-title":"Bone Res."},{"key":"19034_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrmicro2508","volume":"9","author":"GE Thwaites","year":"2011","unstructured":"Thwaites, G. E. & Gant, V. Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?. Nat. Rev. Microbiol. 9, 215\u2013222 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"19034_CR14","first-page":"603","volume":"5","author":"E Muraille","year":"2014","unstructured":"Muraille, E., Leo, O. & Moser, M. Th1\/Th2 paradigm extended: Macrophage polarization as an unappreciated pathogen-driven escape mechanism? Front. Immunol. 5,  603 (2014).","journal-title":"Front. Immunol."},{"issue":"19","key":"19034_CR15","doi-asserted-by":"publisher","first-page":"e141164","DOI":"10.1172\/jci.insight.141164","volume":"5","author":"E Nishitani","year":"2020","unstructured":"Nishitani, K. et al. IsdB antibody-mediated sepsis following S. aureus surgical site infection. JCI Insight 5(19), e141164 (2020).","journal-title":"JCI Insight"},{"key":"19034_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215035","volume":"14","author":"CAMM L\u00f6wik","year":"2019","unstructured":"L\u00f6wik, C. A. M. M. et al. Obese patients have higher rates of polymicrobial and Gram-negative early periprosthetic joint infections of the hip than non-obese patients. PLoS ONE 14, e0215035 (2019).","journal-title":"PLoS ONE"},{"key":"19034_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner, J. R. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9, 799\u2013809 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"19034_CR18","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ncpgasthep0259","volume":"2","author":"A Fasano","year":"2005","unstructured":"Fasano, A. & Shea-Donohue, T. Mechanisms of disease: The role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 416\u2013422 (2005).","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"19034_CR19","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1136\/gut.2005.085373","volume":"55","author":"MC Arrieta","year":"2006","unstructured":"Arrieta, M. C., Bistritz, L. & Meddings, J. B. Alterations in intestinal permeability. Gut 55, 1512\u20131520 (2006).","journal-title":"Gut"},{"key":"19034_CR20","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/S0140-6736(00)02169-3","volume":"355","author":"A Fasano","year":"2000","unstructured":"Fasano, A. et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355, 1518\u20131519 (2000).","journal-title":"Lancet"},{"key":"19034_CR21","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1242\/jcs.113.24.4435","volume":"113","author":"W Wang","year":"2000","unstructured":"Wang, W., Uzzau, S., Goldblum, S. E. & Fasano, A. Human zonulin, a potential modulator of intestinal tight junctions. J. Cell Sci. 113, 4435\u20134440 (2000).","journal-title":"J. Cell Sci."},{"key":"19034_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.12688\/f1000research.20510.1","volume":"9","author":"A Fasano","year":"2020","unstructured":"Fasano, A. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Research 9, 69 (2020).","journal-title":"F1000Research"},{"key":"19034_CR23","doi-asserted-by":"publisher","first-page":"S325","DOI":"10.1016\/j.arth.2018.09.045","volume":"34","author":"N Shohat","year":"2019","unstructured":"Shohat, N. et al. Hip and knee section, what is the definition of a periprosthetic joint infection (PJI) of the knee and the hip? Can the same criteria be used for both joints?: Proceedings of international consensus on orthopedic infections. J. Arthroplasty 34, S325\u2013S327 (2019).","journal-title":"J. Arthroplasty"},{"key":"19034_CR24","doi-asserted-by":"crossref","unstructured":"Peterson, D. A. & Jimenez Cardona, R. A. Specificity of the adaptive immune response to the gut microbiota. In Advances in immunology vol. 107 71\u2013107 (2010).","DOI":"10.1016\/B978-0-12-381300-8.00003-4"},{"key":"19034_CR25","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-074937","author":"K Honda","year":"2012","unstructured":"Honda, K. & Littman, D. R. The microbiome in infectious disease and inflammation. Annu. Rev. Immunol. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-074937 (2012).","journal-title":"Annu. Rev. Immunol."},{"issue":"18","key":"19034_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41579-020-0367-2","volume":"2020","author":"WE Ruff","year":"2020","unstructured":"Ruff, W. E., Greiling, T. M. & Kriegel, M. A. Host\u2013microbiota interactions in immune-mediated diseases. Nat. Rev. Microbiol. 2020(18), 521\u2013538 (2020).","journal-title":"Nat. Rev. Microbiol."},{"issue":"588","key":"19034_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-020-2971-8","volume":"2020","author":"J Schluter","year":"2020","unstructured":"Schluter, J. et al. The gut microbiota is associated with immune cell dynamics in humans. Nature 2020(588), 303\u2013307 (2020).","journal-title":"Nature"},{"key":"19034_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/gutjnl-2018-317726","volume":"69","author":"T Joeri","year":"2020","unstructured":"Joeri, T. et al. Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction. Gut 69, 191\u2013193 (2020).","journal-title":"Gut"},{"key":"19034_CR29","doi-asserted-by":"publisher","first-page":"e1251384","DOI":"10.1080\/21688370.2016.1251384","volume":"4","author":"S Craig","year":"2016","unstructured":"Craig, S. & Alessio, F. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers 4, e1251384 (2016).","journal-title":"Tissue Barriers"},{"key":"19034_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.plabm.2017.09.001","volume":"9","author":"M Mal\u00ed\u010dkov\u00e1","year":"2017","unstructured":"Mal\u00ed\u010dkov\u00e1, M. et al. Fecal zonulin is elevated in Crohn\u2019s disease and in cigarette smokers. Pract. Lab. Med. 9, 39\u201344 (2017).","journal-title":"Pract. Lab. Med."},{"issue":"9","key":"19034_CR31","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/nu9090962","volume":"9","author":"K Aleksandrova","year":"2017","unstructured":"Aleksandrova, K., Romero-Mosquera, B. & Hernandez, V. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention. Nutrients 9(9), 962 (2017).","journal-title":"Nutrients"},{"key":"19034_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/CORR.0000000000000851","author":"CJ Hernandez","year":"2019","unstructured":"Hernandez, C. J. et al. Disruption of the gut microbiome increases the risk of periprosthetic joint infection in mice. Clin. Orthop. Relat. Res. https:\/\/doi.org\/10.1097\/CORR.0000000000000851 (2019).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"19034_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin, Y., Seldin, M. & Lusis, A. Multi-omics approaches to disease. Genome Biol. 18, 1\u201315 (2017).","journal-title":"Genome Biol."},{"key":"19034_CR34","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1128\/MMBR.64.4.847-867.2000","volume":"64","author":"ME Davey","year":"2000","unstructured":"Davey, M. E. & O\u2019toole, G. A. Microbial biofilms: From ecology to molecular genetics. Microbiol. Mol. Biol. Rev. 64, 847\u2013867 (2000).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"19034_CR35","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S1473-3099(19)30529-8","volume":"19","author":"J-F Gu\u00e9gan","year":"2019","unstructured":"Gu\u00e9gan, J.-F. The nature of ecology of infectious disease. Lancet Infect. Dis. 19, 1296 (2019).","journal-title":"Lancet Infect. Dis."},{"issue":"449","key":"19034_CR36","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature06246","volume":"2007","author":"R Medzhitov","year":"2007","unstructured":"Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 2007(449), 819\u2013826 (2007).","journal-title":"Nature"},{"issue":"30","key":"19034_CR37","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"2020","author":"D Zheng","year":"2020","unstructured":"Zheng, D., Liwinski, T. & Elinav, E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020(30), 492\u2013506 (2020).","journal-title":"Cell Res."},{"issue":"6252","key":"19034_CR38","doi-asserted-by":"publisher","first-page":"1259504","DOI":"10.1126\/science.1259504","volume":"348","author":"PTJ Johnson","year":"2015","unstructured":"Johnson, P. T. J., Roode, J. C. de & Fenton, A. Why infectious disease research needs community ecology. Science. 349(6252), 1259504 (2015).","journal-title":"Science"},{"key":"19034_CR39","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/QAD.0000000000000735","volume":"29","author":"CL Shive","year":"2015","unstructured":"Shive, C. L., Jiang, W., Anthony, D. D. & Lederman, M. M. Soluble CD14 is a nonspecific marker of monocyteactivation. AIDS 29, 1263 (2015).","journal-title":"AIDS"},{"key":"19034_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/09680519050110040701","volume":"11","author":"K Rl","year":"2005","unstructured":"Rl, K. & Pa, T. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J. Endotoxin Res. 11, 225\u2013229 (2005).","journal-title":"J. Endotoxin Res."},{"key":"19034_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21186782","volume":"21","author":"L S\u00e1nchez-Alcoholado","year":"2020","unstructured":"S\u00e1nchez-Alcoholado, L. et al. Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer. Int. J. Mol. Sci. 21, 1\u201320 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"19034_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1152\/physrev.00003.2008","volume":"91","author":"A Fasano","year":"2011","unstructured":"Fasano, A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol. Rev. 91, 151\u2013175 (2011).","journal-title":"Physiol. Rev."},{"key":"19034_CR43","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/S0140-6736(00)02169-3","volume":"355","author":"A Fasano","year":"2000","unstructured":"Fasano, A. et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet (London, England) 355, 1518\u20131519 (2000).","journal-title":"Lancet (London, England)"},{"key":"19034_CR44","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41467-020-15831-7","volume":"11","author":"N Tajik","year":"2020","unstructured":"Tajik, N. et al. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat. Commun.  11, 1995 (2020).","journal-title":"Nat. Commun."},{"key":"19034_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/674106","volume":"2013","author":"A Zak-Go\u0142\u0105b","year":"2013","unstructured":"Zak-Go\u0142\u0105b, A. et al. Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int. J. Endocrinol. 2013, 674106 (2013).","journal-title":"Int. J. Endocrinol."},{"key":"19034_CR46","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","volume":"76","author":"F Ciccia","year":"2017","unstructured":"Ciccia, F. et al. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann. Rheum. Dis. 76, 1123\u20131132 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"19034_CR47","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.cgh.2012.08.012","volume":"10","author":"A Fasano","year":"2012","unstructured":"Fasano, A. Intestinal permeability and its regulation by Zonulin: Diagnostic and therapeutic implications. Clin. Gastroenterol. Hepatol. 10, 1096\u20131100 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"19034_CR48","doi-asserted-by":"publisher","first-page":"29142","DOI":"10.1038\/srep29142","volume":"6","author":"C Li","year":"2016","unstructured":"Li, C. et al. Zonulin regulates intestinal permeability and facilitates enteric bacteria permeation in coronary artery disease. Sci. Rep. 6, 29142 (2016).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19034-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19034-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19034-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T16:12:50Z","timestamp":1662394370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19034-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19034"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19034-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15094"}}